Results
197
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
197 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARBE | US$2.42 | -16.0% | 38.3% | US$245.2m | US$4.00 | PS227.2x | E67.8% | n/a | Tech | ||
KRYS | US$182.62 | 17.3% | 63.1% | US$5.1b | US$211.44 | PE59x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
EUDA | US$4.11 | 0.2% | 186.4% | US$147.4m | US$6.00 | PS38.5x | E101.4% | n/a | Healthcare | ||
FINW | US$19.95 | 0.8% | 112.0% | US$272.6m | US$21.67 | PB1.5x | E33.0% | n/a | Banks | ||
FSI | US$6.57 | 3.0% | 236.9% | US$84.2m | US$9.00 | PE19.7x | E48.1% | 1.5% | Materials | ||
LQDA | US$16.50 | 2.2% | 17.5% | US$1.4b | US$25.33 | PS89.5x | E57.4% | n/a | Pharmaceuticals & Biotech | ||
BRDG | US$8.07 | 4.4% | 9.9% | US$990.5m | US$9.10 | PE96.2x | E51.4% | 8.2% | Diversified Financials | ||
VRAR | US$1.57 | -13.3% | 6.8% | US$35.1m | US$4.67 | PS3.6x | E174.2% | n/a | Software | ||
YTRA | US$1.01 | -1.9% | -36.5% | US$60.2m | US$2.99 | PS0.8x | E93.7% | n/a | Consumer Services | ||
CCB | US$91.47 | 2.4% | 135.5% | US$1.4b | US$100.00 | PB4.1x | E49.2% | n/a | Banks | ||
SURG | US$1.40 | -6.0% | -81.0% | US$28.4m | US$5.75 | PS0.3x | E107.1% | n/a | Telecom | ||
PLX | US$2.43 | -8.6% | 69.9% | US$184.1m | US$14.50 | PS3.9x | E123.8% | n/a | Pharmaceuticals & Biotech | ||
PAL | US$10.76 | -2.7% | n/a | US$294.9m | US$15.67 | PS2x | E79.1% | n/a | Transportation | ||
DUOL | US$421.78 | -2.0% | 138.3% | US$19.0b | US$352.52 | PE213.8x | E35.5% | n/a | Consumer Services | ||
NIU | US$2.25 | 2.7% | 28.6% | US$165.3m | US$2.41 | PS0.4x | E125.9% | n/a | Automobiles | ||
BCAL | US$16.08 | -2.4% | 7.5% | US$524.3m | US$20.00 | PB1x | E67.3% | n/a | Banks | ||
KULR | US$2.05 | -8.9% | 1,453.6% | US$428.2m | US$4.22 | PS45.2x | E78.9% | n/a | Capital Goods | ||
HROW | US$30.13 | -5.6% | 171.0% | US$1.1b | US$57.88 | PS6.3x | E81.8% | n/a | Pharmaceuticals & Biotech | ||
RCAT | US$8.50 | -9.9% | 1,097.2% | US$700.6m | US$13.50 | PS41.4x | E106.1% | n/a | Tech | ||
ASPI | US$4.90 | -14.0% | 22.5% | US$339.1m | US$6.50 | PS103.4x | E62.6% | n/a | Materials | ||
GHLD | US$12.44 | 1.6% | -12.5% | US$751.9m | US$15.83 | PS0.9x | E114.5% | 4.0% | Diversified Financials | ||
MAX | US$11.77 | -10.4% | -41.0% | US$840.0m | US$21.43 | PE67.4x | E35.3% | n/a | Media | ||
BHST New | US$5.31 | -5.2% | -6.7% | US$98.6m | US$14.67 | PS4.1x | E63.4% | n/a | Household | ||
FUTU | US$120.59 | 2.3% | 138.9% | US$16.7b | US$126.37 | PE29.1x | E24.7% | 1.6% | Diversified Financials |